Radison Labs Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 15-06-2024
- Paid Up Capital ₹ 7.50 Cr
as on 15-06-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 39.69 Cr
as on 15-06-2024
- Satisfied Charges ₹ 31.38 Cr
as on 15-06-2024
- Revenue 28.18%
(FY 2023)
- Profit 41.47%
(FY 2023)
- Ebitda 21.49%
(FY 2023)
- Net Worth 16.08%
(FY 2023)
- Total Assets 18.04%
(FY 2023)
About Radison Labs
The Corporate was formerly known as Sahithi Drugs & Intermediates Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.50 Cr.
The company currently has active open charges totaling ₹39.69 Cr. The company has closed loans amounting to ₹31.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venugopala Dandu, Pathapati Raju, and Pathapati Lakshmi serve as directors at the Company.
- CIN/LLPIN
U24232TG2006PTC051910
- Company No.
051910
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Radison Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pathapati Raju  | Managing Director | 24-Feb-2014 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venugopala Dandu | Director | 24-Feb-2014 | Current |
| Pathapati Lakshmi | Director | 24-Feb-2014 | Current |
Financial Performance of Radison Labs.
Radison Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.18% increase. The company also saw a substantial improvement in profitability, with a 41.47% increase in profit. The company's net worth Soared by an impressive increase of 16.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radison Labs?
In 2023, Radison Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sadanjana Pharma Private LimitedActive 14 years 5 monthsVenugopala Dandu and Pathapati Raju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Mar 2022 | ₹2.71 M | Open |
Others Creation Date: 31 Jan 2022 | ₹9.22 M | Open |
Hdfc Bank Limited Creation Date: 15 Jun 2020 | ₹38.50 Cr | Open |
How Many Employees Work at Radison Labs?
Radison Labs has a workforce of 133 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radison Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radison Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
